Genetic Signatures Limited (ASX:GSS)
0.0870
+0.0060 (7.41%)
Sep 8, 2026, 1:35 PM AEST
Genetic Signatures Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -14.01 | -20.1 | -17.86 | -14.05 | 3.06 |
Depreciation & Amortization | 2.06 | 2.42 | 2 | 1.53 | 1.62 |
Loss (Gain) From Sale of Assets | 0.31 | -0.06 | 0.01 | - | 0.06 |
Asset Writedown & Restructuring Costs | 2.08 | 6.99 | - | - | - |
Stock-Based Compensation | -0.19 | 0.74 | 0.9 | 1.97 | 1.92 |
Provision & Write-off of Bad Debts | 0 | -0.01 | 0.02 | -0.26 | 0.12 |
Other Operating Activities | 0.07 | 0.29 | 0.69 | 0.55 | -0.65 |
Change in Accounts Receivable | 0.33 | 0.27 | -0.17 | 0.5 | 1.24 |
Change in Inventory | 2.78 | -2.75 | 1.62 | 1.03 | 1.93 |
Change in Accounts Payable | -0.97 | -0.81 | -0.08 | 0.51 | 0.31 |
Change in Other Net Operating Assets | -0.24 | 0.73 | 2.76 | -4.21 | 0.2 |
Operating Cash Flow | -7.77 | -12.29 | -10.12 | -12.45 | 9.81 |
Operating Cash Flow Growth | - | - | - | - | 133.75% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -1.05 | -0.65 | -1.98 | -1.93 | -1.71 |
Sale (Purchase) of Intangibles | - | -0.25 | -2.81 | -6.16 | -1.28 |
Investment in Securities | 10.9 | -23.4 | - | - | - |
Investing Cash Flow | 9.85 | -24.3 | -4.79 | -8.09 | -2.99 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | -0.48 | -0.43 | -0.18 | -0.03 | -0.37 |
Lease Payments | -0.48 | -0.43 | -0.18 | -0.03 | -0.37 |
Net Debt Issued (Repaid) | -0.48 | -0.43 | -0.18 | -0.03 | -0.37 |
Issuance of Common Stock | - | 8.77 | 37.52 | 0.01 | 0.27 |
Other Financing Activities | - | -0.55 | -2.53 | -0 | -0.01 |
Financing Cash Flow | -0.48 | 7.79 | 34.82 | -0.02 | -0.1 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.01 | 0.03 | -0 | 0.02 | 0.06 |
Net Cash Flow | 1.59 | -28.78 | 19.9 | -20.55 | 6.78 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -8.82 | -12.94 | -12.1 | -14.38 | 8.09 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -45.62% | -65.52% | -87.88% | -66.86% | 22.80% |
Free Cash Flow Per Share | -0.04 | -0.06 | -0.07 | -0.10 | 0.06 |
Levered Free Cash Flow | -5.1 | -8.5 | -10.88 | -18.1 | 6.08 |
Unlevered Free Cash Flow | -5.07 | -8.44 | -10.86 | -18.1 | 6.09 |
Free Cash Flow After Leases | -9.3 | -13.37 | -12.28 | -14.42 | 7.73 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.05 | 0.09 | 0.04 | 0 | 0.02 |
Change in Working Capital | 1.9 | -2.55 | 4.12 | -2.19 | 3.68 |